ABT earnings: next report 2026-10-21, real EPS beat/miss history, analyst consensus Buy, P/E 32.34. Updated 2026-07-23.
Abbott Laboratories (ABT) Research Hub
Abbott Laboratories (ABT) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 101.96 USD (-3.11%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 32.34, market cap 175.30B. This hub links to the full technical, earnings and options research available for ABT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 101.96 USD (-3.11%) |
| 52-week range | 87.21 USD – 116.72 USD |
| Trend regime | Range |
| 14-day RSI | 38.4 (Bearish) |
| Trailing P/E | 32.34 |
| Market cap | 175.30B |
| Dividend yield | 2.47% |
| Next earnings | 2026-10-21 |
Available research for ABT
Covered Call on ABT: how it works, illustrative setup around the real 101.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ABT: how it works, illustrative setup around the real 101.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ABT: how it works, illustrative setup around the real 101.96 USD price, max profit/loss, breakeven and when to use it. Educational.
ABT technical analysis: range, last 101.96 USD, RSI 38.4, 52w range 87.21 USD–116.72 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ABT in?
Abbott Laboratories (ABT) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is ABT in an uptrend or downtrend?
As of 2026-09-11, ABT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ABT's trailing P/E ratio?
ABT's trailing P/E is 32.34, with a market cap of 175.30B. See the earnings research page for full valuation detail.
When does ABT next report earnings?
ABT is next scheduled to report earnings on 2026-10-21, with a consensus EPS estimate of 1.42 USD.